A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia. [electronic resource]
Producer: 19890504Description: 21-4 p. digitalISSN:- 0093-7754
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Clinical Trials as Topic
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Female
- Humans
- Idarubicin -- administration & dosage
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Random Allocation
- Remission Induction
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.